Peran Omega 3 Dalam Terapi Skizofrenia

Referensi : 

• Berger, G. E., Proffitt, T.-M., McConchie, M., Yuen, H., Wood, S. J., Amminger, G. P., & Miller, B. J. (2020). Omega-3 supplementation in schizophrenia: A meta-analysis of randomized controlled trials. Neuropsychopharmacology, 45(7), 1156--1163.
• Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck Jr, P. E., Marangell, L. B., Richardson, A. J., Lake, J., Stoll, A. L., & Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry (2019). Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry, 80(5).
• Firth, J., Stubbs, B., Sarris, J., Rosenbaum, S., Teasdale, S. B., Berk, M., & Yung, A. R. (2017). The effects of omega-3 fatty acids in adults with schizophrenia: A systematic review and meta-analysis. Pharmacological Research, 124, 105--115.
• Ross, B. M., Seguin, J., & Sieswerda, L. E. (2007). Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids in Health and Disease, 6, 21.
• Su, K.-P., Huang, S.-Y., Chiu, C.-C., & Shen, W. W. (2003). Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology, 13(4), 267--271.